Methodological considerations on the predictive value of tumor-infiltrating lymphocytes for pathological complete response in early triple-negative breast cancer. Ali M. Breast Cancer Res Treat 2026;218:28.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ali M. Methodological considerations on the predictive value of tumor-infiltrating lymphocytes for pathological complete response in early triple-negative breast cancer. Breast Cancer Res Treat 2026;218:28.
PMID: 42550285